![Dirk Plaga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Plaga worked as the Chief Financial Officer at Bayer AG and as the Executive Vice President-Global Finance at Evotec SE.
He also served as the Chief Financial Officer at Vita 34 AG from 2022 to 2024.
Mr. Plaga completed his undergraduate degree at Ruhr-Universität Bochum.
| Unternehmen | Position | Ende |
|---|---|---|
| FAMICORD AG | Finanzdirektor/CFO | 01.08.2024 |
| EVOTEC SE | Corporate Officer/Principal | - |
| BAYER AG | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Ruhr-Universität Bochum
 Ruhr-Universität Bochum Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vita 34 AG
 Vita 34 AG BiotechnologyHealth Technology Provides umbilical stem cell preservation and cord blood-banking services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
